Global Analgesics Industry

NEW YORK, March 16, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p098419/Global-Analgesics-Industry.html

This report analyzes the worldwide markets for Analgesics in US$ Million by the following segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others (includes combination drugs)), and External Analgesics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 137 companies including many key and niche players such as Bayer Consumer Care, Johnson & Johnson, McNeil Consumer Healthcare, Novartis International AG, Pfizer, Inc., Reckitt Benckiser Group Plc, and Sanofi Aventis S.A. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Internal Analgesics - The Largest & Fastest Growing Market 5

Global Analgesics Market (2007): Leading Analgesics Brands by

PolyAspirin: The Safer and More Potent Polymer Variant of

Acetaminophen Reduces Incidence of Ovarian Cancer 15

Table 1: Opioid Analgesics Market: Percentage Share of Opioid

/ Acetaminophen Combination Products in the Opioid Script

Novel Therapies to Propel Opioid and Non-Opioid Therapies 18

Neurodiscovery Receives Approval for NSL-101 Phase II Clinical

Nutra Pharma Commences Online Sales of Cobroxin 20

MIP Technologies and Supelco Introduce Unique SPE Product 21

ProEthic Pharmaceuticals Releases Ibudone for Acute Pain

Dr. Reddy's Laboratories Introduces Supanac for Acute Pain

Teva Pharmaceutical Announces the Launch of Fentanyl

Dr. Reddy's Laboratories Introduces Supanac NSAID Drug 22

7. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE

Mallinckrodt Introduces Magnacet(TM) Tablets for Pain Management 23

Paladin Labs and Labopharm Introduce Tridural(TM) 23

Mentholatum Company Introduces WellPatch Deep Heat Patch 24

Par Pharmaceutical Secures Approval for Marketing Tramadol ER 25

Cipher Acquires Tentative Approval for Tramadol ER Capsules 25

Lannett Receives Approval for Developing Hydromorphone

King Pharmaceuticals Receives Approval for Embeda Pain-Relief

Sangart Secures EC's Orphan Drug Designation for MP4CO 26

Elite Pharmaceuticals and PharmaNetwrok Receive FDA Approval 26

China Life Insurance Inks Agreement with Sino Biopharmaceutical 27

Azur Pharma Inks Agreement with Elan Pharmaceuticals 27

Taisho Pharmaceutical Takes Over OTC Drugs Business of

Piramal Healthcare Acquires Minrad International 28

Biocon Acquires Bulk Pharmaceuticals Unit of Hindujas 28

Sanofi-aventis Mexico Takes Over Laboratorios Kendrick 28

Astellas Acquires Exclusive rights to Pain-Relief Drug from

Henan Lingrui Pharma Commences Construction of New Analgesic

Labopharm Europe Enters into Agreement with Merck Sharp & Dohme 29

Cumberland Pharmaceuticals Enters into a Commercialization

Cumberland Pharmaceuticals Inks an Exclusive Agreement with

Mallinckrodt Acquires Rights of Exalgo Extended-Release

Labopharm Europe and Grunenthal Sign Distribution and Supply

Timm Medical and Ferring Co-promote Prosed DS in the US 30

Competitive Technologies and Fintrade Medical Ink Sales and

Accumetrics and Endotech Ink Exclusive Distribution Agreement 31

Astellas and NeurogesX Sign Distribution and Marketing Agreement 31

Akela Pharma Inks Agreement with Teikoku Seiyaku 31

Medical Nutrition Inks Exclusive Licensing Agreement with DSE

Echo Therapeutics Inks a Licensing Deal with Ferndale Pharma 32

Circ Pharma Signs a Development Agreement with Elan 33

Orexo Inks Distribution Agreement with Neopharm 33

Orexo Inks Agreement with NovaMed Pharmaceuticals 33

Caraco Pharmaceutical Launches Oxycodone Hydrochloride Tablet 34

Pharmaceutical Associates Receives Approval from FDA 34

Nycomed and Paladin Inks Joint-Promotion Agreement for Tridural 35

Daiichi and Lead Chemical Receives Approval for LoxoninÃ’ Tape 35

Tokio Marine Capital Acquires Showa Yakuhin Kako 36

Corgenix Receives EPO Approval for Aspirin Resistance Method 36

American Oriental Bioengineering Partners with China Aoxing 36

Abraxis Takes Over Shimoda and its Subsidiary Company 36

Church & Dwight Snaps Up Del Pharmaceuticals from Coty 37

Sosei Group Corp Re-Acquires Rights to Commercialize AD 923 37

ProStrakan Group Inks Agreement with Paladin Labs 37

Anika Therapeutics Inks Distribution Agreement with DePuy Mitek 38

Albemarle Appoints Dr. Reddy's as Distributor of Bulk

Competitive Technologies and ELS Join Forces to Distribute

10. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 41

Auriga and Mikart Inks Agreement to Market Codein 41

Watson Receives FDA Approval for Oxycodone Hydrochloride and

Labopharm's Tramadol Receives Approval in Canada 41

Grunenthal's Extends Licensing Agreement with Ortho-McNeil 42

Beijing Med-Pharm Inks Agreement with Lotus Healthcare 42

LAB International Inks Licensing Agreement with Janssen

Antares Enters into License and Development Agreement for

Abraxis BioScience Acquires AstraZeneca's Analgesic Brand

IntelliPharmaCeutics Inks Agreement with Larasan 43

Ranbaxy and Ethypharm Ink In-licensing Agreement 44

Elite Collaborates with TPN to Co-develop Analgesic Drug 44

Novartis Acquires Hexal Company and Major Stake in Eon Labs . 44

NovaDel Pharma Receives Patent for Buccal Sprays Technology 44

Auxilium Pharmaceuticals Enters into a Licensing Agreement

EpiCept Corp. Merges with Maxim Pharmaceuticals, Inc 45

Reckitt Benckiser plc Acquires Boots Healthcare International 45

Table 2: World Recent Past, Current & Future Analysis for

Analgesics by Geographic Region/Country - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

Table 3: World Historic Review for Analgesics by Geographic

Region/Country - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 4: World 11-Year Perspective for Analgesics by

Geographic Region/Country - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for

Table 5: World Recent Past, Current & Future Analysis for

Internal Analgesics by Geographic Region/ Country - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

Table 6: World Historic Review for Internal Analgesics by

Geographic Region / Country - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2006 (includes

Table 7: World 11-Year Perspective for Internal Analgesics by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

Table 8: World Recent Past, Current & Future Analysis for

Acetaminophen, Ibuprofen, and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for

Years2007 through 2015 (includes corresponding Graph/Chart) 54

Table 9: World Historic Review for Internal Analgesics by

Product Segment - Aspirin, Acetaminophen, Ibuprofen, and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

Table 10: World 11-Year Perspective for Internal Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Aspirin, Acetaminophen, Ibuprofen, and Others Markets for

Table 11: World Recent Past, Current & Future Analysis for

Aspirin by Geographic Region/Country - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

Table 12: World Historic Review for Aspirin by Geographic

Region/Country - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 13: World 11-Year Perspective for Aspirin by Geographic

Region/Country - Percentage Breakdown of Dollar Sales for US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

Table 14: World Recent Past, Current & Future Analysis for

Acetaminophen by Geographic Region/ Country - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years2007 through 2015

Table 15: World Historic Review for Acetaminophen by

Geographic Region/Country - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2006 (includes

Table 16: World 11-Year Perspective for Acetaminophen by

Geographic Region/Country - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

Table 17: World Recent Past, Current & Future Analysis for

Ibuprofen by Geographic Region/Country - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

Table 18: World Historic Review for Ibuprofen by Geographic

Region/Country - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 19: World 11-Year Perspective for Ibuprofen by

Geographic Region/Country - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

Table 20: World Recent Past, Current & Future Analysis for

Other Internal Analgesics by Geographic Region/Country - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years2007 through 2015

Table 21: World Historic Review for Other Internal Analgesics

by Geographic Region/Country - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2006 (includes

Table 22: World 11-Year Perspective for Other Internal

Analgesics by Geographic Region/Country - Percentage Breakdown

of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Table 23: World Recent Past, Current & Future Analysis for

External Analgesics by Geographic Region/ Country - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 2015

Table 24: World Historic Review for External Analgesics by

Geographic Region / Country - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2007 (includes

Table 25: World 11-Year Perspective for External Analgesics by

Geographic Region /Country - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for

Table 26: US Analgesics Market (2009): Percentage Share

Breakdown of Leading Manufacturers by Sales (includes

Table 27: US Internal Liquid Analgesics Market (2009):

Percentage Share Breakdown of Leading Brands by Sales

Table 28: US Internal Tablet Analgesics Market (2009):

Percentage Share Breakdown of Leading Brands by Sales

Table 29: Internal Analgesics Market in the US by Retail

Channel (2008): Percentage Share by Value Sales for

Discount Stores, Food/Drug Combination Stores, Chain Drug

Promotional Strategies for the Internal Analgesics 75

Table 30: Market for Internal Liquid Analgesics in the

U.S. by Retail Channel (2008): Percentage Share by Value

Sales for Supermarkets, Drug Stores, and Discounters

Table 31: US External Analgesics Market (2007):

Percentage Share Breakdown of Leading Ten Brands by

Table 32: External Analgesics Market in the US by Retail

Channel (2008): Percentage Share by Value Sales for Chain

drug stores, Discount stores, Food/drug combination

Rubs, Patches: Driving the External Analgesics Market 77

Table 33: US Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

Table 34: US Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 35: US 11-Year Perspective for Analgesics by Product

Segment - Percentage Breakdown of Dollar Sales for Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

Table 36: Canadian Recent Past, Current & Future Analysis

for Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

Table 37: Canadian Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 38: Canadian 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 &

Table 39: OTC Analgesics Market in Japan (2005): Market

Share of Leading Players by Value - Lion, Arax, Taisho

Pharmaceutical, SS Pharmaceutical, Shionogi, and Others

Table 40: Japanese Recent Past, Current & Future Analysis

for Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

Table 41: Japanese Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 42: Japanese 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Table 43: Popular Brands of Pain & Inflammation Medication

in Europe (2004): Percentage Share of Aspirin, Voltaren,

Ibuprofen, Nurofen, Vioxx, Celebre, Tylenol, Aulin, Anadin,

and Paracetamol (includes corresponding Graph/Chart) 88

Table 44: European Recent Past, Current & Future Analysis

for Analgesics by Geographic Region/Country - France,

Germany, UK, Italy, Spain, Russia and Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years2007 through 2015 (includes corresponding

Table 45: European Historic Review for Analgesics by

Geographic Region/Country - France, Germany, UK, Italy,

Spain, Russia and Rest of Europe Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

Table 46: European 11-Year Perspective for Analgesics by

Geographic Region/Country - Percentage Breakdown of Dollar

Sales for France, Germany, UK, Italy, Spain, Russia and Rest

Table 47: European Recent Past, Current & Future Analysis

for Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

Table 48: European Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2007 (includes corresponding

Table 49: European 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for Years 2005, 2010 &

Table 50: Analgesics Market in France (2005): Market Share

of Leading Players by Value - Bristol-Myers Squibb,

Therapix, Roche, Bayer Group, Wyeth Consumer Healthcare,

and Others) (includes corresponding Graph/Chart) 95

Table 51: French Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

Table 52: French Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 53: French 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 &

Table 54: Analgesics Market in Germany (2005): Market Share

of Leading Players by Value - Bayer Group, Boehringer

Ingelheim, Wyeth Consumer Healthcare, and Others (includes

Table 55: German Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

Table 56: German Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 57: German 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 &

Table 58: Analgesics Market in Italy (2005): Market Share

of Leading Players by Value - Bayer Group, Angelini,

Novartis, Bristol-Myers Squibb, and Others (includes

Table 59: Italian Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

Table 60: Italian Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 61: Italian 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Table 62: Analgesics Market in the United Kingdom (2005E):

Table 63: UK Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

Table 64: UK Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Table 65: UK 11-Year Perspective for Analgesics by Product

Segment - Percentage Breakdown of Dollar Sales for Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

Table 66: Analgesics Market in Spain (2005): Market Share

of Leading Players by Value - Bayer Group, Boehringer

Healthcare, and Others (includes corresponding Graph/Chart) 111

Table 67: Spanish Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

Table 68: Spanish Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006(includes corresponding

Table 69: Spanish 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Table 70: Rest of Europe Recent Past, Current & Future

Analysis for Analgesics by Product Segment - Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years2007 through

Table 71: Rest of Europe Historic Review for Analgesics by

Acetaminophen, Ibuprofen and Others) and External Analgesics

Markets Independently Analyzed with Annual Sales Figures in

Table 72: Rest of Europe 11-Year Perspective for Analgesics

by Product Segment - Percentage Breakdown of Dollar Sales

for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen

and Others) and External Analgesics Markets for 2005, 2010 &

OTC Analgesics Market in Asia-Pacific (2004): A Comparative

Analysis of the Major Regions - Australia, China and South

Table 73: Asia-Pacific Recent Past, Current & Future

Analysis for Analgesics by Product Segment - Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years2007 through

Table 74: Asia-Pacific Historic Review for Analgesics by

Acetaminophen, Ibuprofen and Others) and External Analgesics

Markets Independently Analyzed with Annual Sales Figures in

Table 75: Asia-Pacific 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for 2005,2010 &

Table 76: Latin American Recent Past, Current & Future

Analysis for Analgesics by Product Segment - Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

Table 77: Latin American Historic Review for Analgesics by

Acetaminophen, Ibuprofen and Others) and External Analgesics

Markets Independently Analyzed with Annual Sales Figures in

Table 78: Latin American 11-Year Perspective for Analgesics

by Product Segment - Percentage Breakdown of Dollar Sales

for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen

and Others) and External Analgesics Markets for 2005, 2010 &

Table 79: Rest of World Recent Past, Current & Future

Analysis for Analgesics by Product Segment - Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

Table 80: Rest of World Historic Review for Analgesics by

Acetaminophen, Ibuprofen and Others) and External Analgesics

Markets Independently Analyzed with Annual Sales Figures in

Table 81: Rest of World 11-Year Perspective for Analgesics

by Product Segment - Percentage Breakdown of Dollar Sales

for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen

and Others) and External Analgesics Markets for 2005, 2010 &

20. APPENDIX - POPULAR ANALGESIC BRANDS BY REGION 128

Total Companies Profiled: 137 (including Divisions/Subsidiaries - 179)

Source: http://www.sys-con.com